Cambridge Investment Research Advisors
FEED

Cambridge Investment Research Advisors’s ENvue Medical Inc FEED Stock Holding History

Cambridge Investment Research Advisors’s Portfolio FEED Stock Details FEED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$4K – 3216
2022
Q4 		$4K Hold
7
– – ﹤0.01% 3088
2022
Q3 		$7K Buy
7
+1
+17% +$1.3K ﹤0.01% 3029
2022
Q2 		$8K Hold
6
– – ﹤0.01% 3024
2022
Q1 		$14K Hold
6
– – ﹤0.01% 3132
2021
Q4 		$13K Buy
+6
New +$17.8K ﹤0.01% 3144

Other funds holding FEED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFS
Amtrust Financial Services New York $300M AUM 12.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NC
NewSquare Capital Newtown Square, Pennsylvania $1.15B AUM 24.78% 1-Year Est. Return

Cambridge Investment Research Advisors's FEED Position: Q1 2023 in Review

Cambridge Investment Research Advisors sold out of ENvue Medical Inc (FEED) in Q1 2023, closing a stake of 7 shares — an estimated $4K sold.

Cambridge Investment Research Advisors first reported a position in FEED in Q4 2021 and held it in 5 quarters. The position peaked at $14K in Q1 2022. 7 funds tracked by Wall St. Rank hold FEED as of Q1 2023.

  • Cambridge Investment Research Advisors reported no remaining ENvue Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 7 ENvue Medical Inc shares in Q1 2023, an estimated $4K.
  • Cambridge Investment Research Advisors first reported a position in ENvue Medical Inc in Q4 2021 and held it in 5 quarters.
  • Cambridge Investment Research Advisors's ENvue Medical Inc position peaked at $14K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held ENvue Medical Inc as of Q1 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.